Follow The Filings

PTGX Protagonist Therapeutics

Protagonist Therapeutics earnings company data as of 4:04 PM ET 11/13

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 2.19 3.07 Beat +40.2%
Rev $241.3M $274.4M Beat +13.7%

Insider trades

Open-market buys and sales by PTGX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All PTGX insider trades
  • None no insider bought on the open market
  • $31.1M sold by 7 insiders outside a trading plan
  • $51.9M sold by 3 insiders under 10b5-1 plans
  1. Asif Ali CFO
    Planned sale
    $8.3M 58,629 shares at $141.78 50% of stake
    Traded Sep 30 Filed Oct 2
  2. Dinesh V. Ph D. Patel CEO
    Planned sale
    $18.2M 125,000 shares at $145.92 19% of stake
    Traded Sep 8–10 Filed Sep 10
  3. Dinesh V. Ph D. Patel CEO
    Planned sale
    $14.9M 100,000 shares at $148.91 16% of stake
    Traded Aug 10–11 Filed Aug 12
  4. William D. Waddill Director
    Planned sale
    $1.1M 9,000 shares at $117.94 54% of stake
    Traded Jun 23 Filed Jun 25
  5. William D. Waddill Director
    Planned sale
    $969K 9,000 shares at $107.68 54% of stake
    Traded Jun 10 Filed Jun 11
  6. William D. Waddill Director
    Planned sale
    $897K 9,000 shares at $99.64 54% of stake
    Traded May 29 Filed Jun 1
  7. Dinesh V. Ph D. Patel CEO
    Planned sale
    $7.5M 75,000 shares at $100.12 13% of stake
    Traded May 12 Filed May 14
  8. Bryan Giraudo Director
    Sale
    $5.9M 59,130 shares at $100.10
    Traded May 7–8 Filed May 11
  9. Arturo Molina MD Chief Medical Officer
    Sale
    $1.6M 15,000 shares at $104.79 15% of stake
    Traded Mar 26 Filed Mar 27
  10. Harold E. Selick Director
    Sale
    $2.5M 24,000 shares at $105.00 28% of stake
    Traded Mar 26 Filed Mar 27
  11. Asif Ali CFO
    Sale
    $2.6M 24,765 shares at $104.24 29% of stake
    Traded Mar 26 Filed Mar 27
  12. Dinesh V. Ph D. Patel CEO
    Sale
    $5.5M 54,700 shares at $101.00 9.4% of stake
    Traded Mar 24–25 Filed Mar 25
  13. Lewis T. Williams Director
    Sale
    $1.5M 18,000 shares at $82.42 70% of stake
    Traded Feb 17 Filed Feb 18
  14. William D. Waddill Director
    Sale
    $1.7M 20,000 shares at $83.68 72% of stake
    Traded Feb 6 Filed Feb 6
  15. Dinesh V. Ph D. Patel CEO
    Sale
    $4.1M 48,273 shares at $84.18 7.8% of stake
    Traded Jan 23–27 Filed Jan 27

Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 8 stock grants, 5 gifts, and 5 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,7.01,9.01
10-Q
8-K 5.02,5.07,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
DEF 14A FORM- DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 2.02,9.01
10-K
SCHEDULE 13G/A —
SCHEDULE 13G —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf